Five things to know:
1. In the fourth quarter, DePuy Synthes reported a 1 percent decrease in sales to $2.2 billion.
2. Fourth quarter hip sales reached $365 million, flat from the same period last year. Knee sales dropped 1.3 percent to $392 million, while trauma remained flat at $674 million. Spine and other sales dropped 2.9 percent to $831 million.
3. For the full year, DePuy Synthes sales dropped 1.9 percent to $8.8 billion.
4. 2018 full-year breakdown of orthopedic sales includes:
• Hips: $1.4 billion (1.7 percent increase)
• Knees: $1.5 billion (1.4 percent decrease)
• Trauma: $2.7 billion (3.2 percent increase)
• Spine and other: $3.2 billion (7.3 percent decrease)
5. In 2018, the company reported strong market demand for the ACTIS stem.
More articles on orthopedics:
How an orthopedic practice grew revenue 75%, physicians 40% in 5 years
California hospital receives $1M donation for orthopedic robotics center
Moody’s Robotics to expand rapidly in orthopedics
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.